Efficacy of Low-Dose Subcutaneous Interleukin-2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load

The immunologic efficacy of low-dose recombinant interleukin-2 (rIL-2) administered sub-cutaneously (sc) once a day in combination with highly active antiretroviral therapy (HAART) was assessed in a pilot study in patients with advanced human immunodeficiency virus (HIV) disease. Twenty-five persons...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infectious diseases 1999-07, Vol.180 (1), p.56-60
Hauptverfasser:	Arnó, Albert, Ruiz, Lidia, Juan, Manel, Jou, Antoni, Balagué, Montserrat, Zayat, M. Khalil, Marfil, Silvia, Martínez-Picado, Javier, Martínez, Miguel Angel, Romeu, Joan, Pujol-Borrell, Ricardo, Lane, Clifford, Clotet, Bonaventura
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Human viral diseases Infectious diseases Medical sciences Pharmacology. Drug treatments Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!